MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives
Artykuł naukowy w czasopiśmie recenzowanyCzasopismo: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (ISSN: 1422-0067)
Rok wydania: 2022
Strony od-do: 2745
Cytowanie w formacie Bibtex:
@article{1,
author = "Maciej Masłyk",
title = "MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives",
journal = "INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES",
year = "2022",
pages = "2745"
}
Cytowanie w formacie APA:
Masłyk, M. (2022). MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2745.